Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibodies for CFTR studies.

Filipa Mendes1, Carlos M Farinha, Mónica Roxo-Rosa

  • 1Center of Human Genetics, National Institute of Health Dr. Ricardo Jorge, Lisboa, Portugal.

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|October 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of CFTR stability at the plasma membrane-Mechanisms and therapeutic opportunities in cystic fibrosis.

FEBS letters·2026
Same author

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Human molecular genetics·2026
Same author

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

Chemical science·2026
Same author

Aquaporin-3 and aquaporin-5 impact the development of pancreatic ductal adenocarcinoma spheroids.

FEBS open bio·2026
Same author

Characterization of a Low-Energy Cyclotron-Based Proton Beam for Preclinical Radiobiological Studies.

International journal of particle therapy·2026
Same author

Inflammatory stimuli and the rescue of disease-causing CFTR nonsense variants.

The European respiratory journal·2026

Sensitive and specific antibodies are crucial for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein research. This review evaluates the utility of available antibodies for CFTR detection in various biological samples.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Accurate detection of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein is essential for cystic fibrosis (CF) research.
  • A variety of antibodies (Abs) have been developed for CFTR detection.
  • The specificity and sensitivity of these Abs are critical for reliable experimental results.

Purpose of the Study:

  • To review the applicability of commonly used antibodies for CFTR detection.
  • To assess the suitability of Abs for both biochemical and immunocytochemical analyses.
  • To guide researchers in selecting appropriate Abs for CFTR expression studies.

Main Methods:

  • Literature review of existing studies utilizing CFTR antibodies.
  • Analysis of antibody performance in heterologous and endogenous expression systems.

Related Experiment Videos

  • Evaluation of antibody utility in native cells and tissues.

    • Main Results:

    • Not explicitly stated in the abstract, but implies an evaluation of various Abs' effectiveness.
    • Highlights the critical need for well-characterized Abs.
    • Identifies potential limitations or strengths of different commercially available or research-generated Abs.

    Conclusions:

    • The selection of appropriate antibodies is paramount for the success of CFTR expression studies.
    • Further validation and characterization of CFTR antibodies are necessary.
    • This review serves as a resource for researchers in choosing reliable tools for CFTR detection.